INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE

Transcatheter aortic valve replacement in patients with non-calcific aortic stenosis

EuroIntervention 2018;13:e1756-e1763 published online October 2017 published online e-edition February 2018. DOI: 10.4244/EIJ-D-17-00584

Tian-Yuan Xiong1, MD; Yuan Feng1, MD; Yan-Biao Liao1, MD; Yi-Jian Li1, MD; Zhen-Gang Zhao1, MD; Xin Wei1, MD; Yuan-Ning Xu1, MD; Jia-Fu Wei1, MD; Yong Peng1, MD; Nicolo Piazza2, MD, PhD; Darren Mylotte3, MB, MD; Mao Chen1*, MD, PhD

1. Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China; 2. Interventional Cardiology Department, McGill University Health Center, Montréal, QC, Canada; 3. Department of Cardiology, University Hospital, and National University

Aims: Limited information exists describing the results of transcatheter aortic valve replacement (TAVR) in patients with symptomatic severe non-calcific aortic stenosis (AS). We aimed to

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

aortic stenosismultislice computed tomography (msct)transcatheter aortic valve implantation (tavi)

Interventions for valvular diseaseTAVI

Share on Facebook Share on Twitter Share on Linkedin